Services on Demand
- Cited by SciELO
- Access statistics
- Cited by Google
- Similars in SciELO
- Similars in Google
Print version ISSN 1517-8382
Braz. J. Microbiol. vol.43 no.2 São Paulo Apr./June 2012
Amir AzimianI; Shahin Najar-pirayehI, *; Siamak Mirab-SamieeII, V; Mahmood NaderiIII, IV
IDepartment of Medical Bacteriology, School of medical Science, Tarbiat Modares University, Tehran, P.O.BOX: 14115-331
IIFood and Drug Laboratory Research Center, Ministry of Health and Medical Education, No. 408, Emam Khomeini Ave., Tehran 11136-15911, Iran
IIIDepartment of Medical Biotechnology, School of Medical Science, Tarbiat Modares University, Tehran, P.O.BOX: 14115-331
IVMolecular Biology and Genetic Engineering Department, Stem Cell Technology Research Center, Tehran, Iran; 5Reference Health Laboratories, Ministry of Health and Medical Education, Tehran, Iran
Methicillin-Resistant Staphylococcus aureus (MRSA) is responsible for an increasing number of serious hospital and community acquired infections. Virulence gene expression in Staphylococcus aureus is orchestrated by regulators such as the accessory gene regulator (agr). Staphylococcal strains are divided into four major agr groups (agrI-IV) on the basis of agrD and agrC polymorphisms. The purpose of this study was to define the prevalence of MRSA strains in appointed Tehran's hospitals and then to define and compare the proportion of agr I, II, III, IV polymorphisms between MRSA and Methicillin Sensitive Staphylococcus aureus (MSSA) strains. A total of 235 isolates were evaluated by conventional antibiotic susceptibility tests and PCR for agr and mecA genes. 112 strains were MRSA (47.5%) and the most prevalent agr specific group was agr I followed by agr III, agr II and agr IV, respectively. The prevalence of agr groups amongst MRSA and MSSA strains was not statistically significant (P>0.05). This study suggests that agr I is not only the most prevalent agr type in MRSAs but also the most common one in Methicillin Sensitive Staphylococcus aureus (MSSA) strains in Iran.
Key words: Methicillin Resistant Staphylococcus aureus, agr, PCR.
Staphylococcus aureus is the major pathogen responsible for both hospital and community acquired infections. Based on numerous reports S. aureus has become resistant to most available antibiotics (4, 1, 14). In the early 1950s acquisition and spread of beta lactamase producing plasmids thwarted the effectiveness of penicillin for treating S. aureus infections. In 1950 methicillin, a semisynthetic penicillin, was introduced, even though in 1960 methicillin resistant Staphylococcus aureus (MRSA) strains were identified. The mechanism by which S. aureus acquires resistance to Methicillin is dependent upon the production of an altered penicillin binding protein (PBP2a) which is encoded by mecA gene. Increasing number of isolated MRSA strains has led to complication in treatment of staphylococcal diseases (7, 10, 24).
This pathogen causes a wide range of diseases including septicemia, meningitis, endocarditis, osteomyelitis, septic arthritis, toxic shock syndrome and food poisoning (4, 1, 14). The accessory gene regulator (agr) locus was identified as the regulator of virulence factors in S. aureus. It controls a large set of genes, including most of those encoding cell wall associated and extracellular proteins (2, 18). The agr locus is composed of two divergent transcriptional units, RNAII and RNAIII, driven by P2 and P3 promoters, respectively. The P2 operon encodes four proteins that generate the agr-sensing mechanism and as a result of their activation, the effector molecule (RNAIII) is produced and affects the expression of virulence genes. The association between agr specific group, the type of infection, and also antibiotic resistance has been reported by many researchers (29, 30). In this study we investigated the occurrence of the Methicillin Resistant S. aureus (MRSA) among clinical samples while considering their specific accessory gene regulator (agr) groups and the site of infection.
MATERIALS AND METHODS
A total of 235 S. aurous isolates were isolated from patients and healthy individuals. Isolates were taken from blood culture , urine , skin , respiratory tract specimens  and miscellaneous specimens such as tissue biopsies, exudates and bone marrow . Also 31 nasal swabs of S. aureus were taken from healthy volunteers.
S. aureus isolates were identified with the use of conventional tests consisting of gram staining, catalase test, growth in manitol salt agar media, DNase and coagulase test.
Antibiotic susceptibility test
Disk diffusion and MIC agar dilution were performed for all isolates. Disk diffusion and MIC were accomplished according to the guidelines of Clinical and Laboratory Standards Institute (CLSI) (28). We used 1 µg Oxacillin disk (HiMedia Code: SD088) for disk diffusion test. Oxacillin powder (Sigma code: O1002) was utilized for MIC (Agar dilution method) while Staphylococcus aureus ATCC25923 was used as the control.
Genomic DNA extraction
Bacterial DNA lysates were prepared from 1 ml of an overnight Tripticase Soy Broth (TSB) culture. After centrifugation at 6000 g for 5 min the bacterial pellet was resuspended in 500µl of TE buffer [50mM Tris-Hcl (PH=8), 50mM disodium EDTA] containing 20 unit lysostaphin (Sigma code: L7386 ) (25), and incubated at 37°C for 30-60 min and then extracted by conventional Phenol-Chloroform method.
Thermal cycling for amplification of mecA gene was performed in an Eppendorf thermal cycler (Mastercycler® gradient). Amplification protocol consisted of 5 min initial denaturation at 94°C, followed by 30 cycles of denaturation (94°C/30 seconds), annealing (55°C/30 seconds) and extension (72°C/60 seconds), and an additional post-amplification extension step at 72°C for 7 min.
The same device was used for agr group amplification. Amplification protocol consisted of 5 min initial denaturation at 94°C, followed by 30 cycles of denaturation (94°C/60 seconds), annealing (57°C/60 seconds) and extension (72°C/60 seconds), and a final post-amplification extension at 72°C for 7 min (23). The list of primers used for this experiment is depicted in Table 1. The products of amplified samples were analyzed by electrophoresis in a 1% agarose gel and stained with ethidium bromide. S. aureus strains RN6390 (agr groupI), RN6607 (agr groupII), RN8465 (agr groupIII), RN4550 (agr group IV) and RN6911 (agr negative) were included as run controls for agr group identification.
Statistical significance of differences between groups was analyzed by means of T-student or ANOVA test. Multivariate analysis was performed to assess the independence of the statistically significant variables in unvariate analysis. A Ρ-value < 0.05 was considered significant.
A total of 235 strains from patients and healthy individuals (163 men and 72 women; 69% and 31%, respectively) were evaluated. Among the 235 isolates tested by disk diffusion method for detection of oxacillin resistance, 127 strains (54%) were susceptible and 108 strains (46%) showed resistance. By MIC agar dilution method, 130 (55%) strains were susceptible and 105 (45%) strains were resistant. Finally, PCR for mecA gene showed that 110 strains (47%) had mecA gene while 125 strains (53%) showed no amplification for this target.
Our strains were isolated from blood, urine, coetaneous samples, respiratory tract, nasal swabs and miscellaneous samples. Prevalence of MRSA strains in different samples was depicted in Table 2.
Our results showed good correlation between phenotypic and genotypic methods for detection of antibiotic susceptibility tests. According to Table 2, the highest percentage of MRSA strains were isolated from respiratory tract specimens (49%) followed by blood cultures (48%), miscellaneous specimens such as tissue biopsies , exudates and bone marrow (45%), urine (43%), cutaneous specimens (41%) and nasal swabs (34%), respectively. The observed differences were not statistically significant (p>0.05).
The majority of S. aureus strains isolated from clinical and healthy cases belonged to agr group I (128 strains), followed by agr group III (41 strains), agr group II (39 strains) and finally agr group IV (22 strains). Five isolated strains were untypable by our assay (Table 3).
There was a difference in prevalence of specific agr groups between MRSA and MSSA isolates. In MRSA isolates, agr group I had the highest prevalence (57%) followed by group III (19%), group II (14%) and group IV (8%). Two percent of MRSA isolates were untypable. In MSSA isolates, most of the strains belonged to agr group I (52%) followed by group II (19%), group III (16%) and group IV (11%). Two percent of MSSA isolates were untypable. Results are depicted in Table 4. The differences were not statistically significant (P>0.05).
Since the introduction of semisynthetic penicillins such as methicillin and oxacillin for the therapy of infections caused by S. aureus, the occurrence of resistant strains to methicillin has steadily increased and MRSA strains have become the major nosocomial pathogens (19, 27). Infections with MRSA strains require treatment with glycopeptide antibiotics which could be nephro- and ototoxic (9). Staphylococcus aureus is the major pathogen in both community and hospital acquired infections (26). The ability of this organism to cause a multitude of human diseases such as endocarditis, pneumonia, bacteremia and Toxic Shock Syndrome (TSS) suggests that the pathogenesis of Staphylococcus aureus infections is highly complex. The growth phase is not only affected by many cell surface proteins as well as exotoxins but also influenced by the environmental and host signals which contribute to the regulation of virulence factors (18).
The agr operon involves in the coordinated regulation of a number of Staphylococcus aureus virulence factors. Staphylococcus aureus strains exhibit well-defined genetic polymorphisms within the agr locus. Four agr genotypes, group I to IV, have been described to date (4, 6). Although there is massive amounts of data relating agr type and specific infections, Jarraud et al. have shown that specific agr genotype strains may be associated with particular infectious syndromes, with enterotoxin disease linked to agr group I, endocarditis linked to agr groups I and II, toxic shock syndrome linked to agr group III and exofoliative disease linked to agr group IV (12). The agr group III has been overrepresented among strains isolated from community-acquired MRSA infections, whereas agr group II is predominant in isolated MRSA strains from hospitals (17, 21).
In our study, resistance to oxacillin between four agr groups was almost similar. S. aureus strains belonging to agr groups II and IV were equally resistant to oxacillin (41%) whereas strains carrying agr group I and agr group III were more resistant with resistance rates of 50% and 51%, respectively. However, the differences were not statistically significant (P>0.05). Other studies showed a correlation between induction of Glycopeptide Intermediate-resistant Staphylococcus aureus (GISA) phenotype and autolytic deficiency, especially in the context of agr genotype II (13). Some reports stated that there are clinical trends according to each agr group. For example, agr group I was prevalent in a collection of 192 S. aureus strains in which 71% were methicillin resistant (11, 26). Recently, Jarraud et al. reported an overrepresentation of agr genotype II in S. aureus isolates from patients with infective endocarditis (12). Pamela et al. showed that agr group II polymorphism in MRSA predicts the failure of vancomycin therapy (16). Moreover, it has been reported that community-acquired MRSA, Methicillin Sensitive S. aureus (MSSA) (3, 20) and Toxic Shock Syndrome Toxin (TSST-1) producing isolates belong to agr specificity group III (6).
In our study most of MRSA strains belonged to agr group I and III, respectively, and most of MSSA strains belonged to agr groups II and IV (%59). Van Leeuwen et al. screened a collection of 55 MSSA isolates, mostly taken from healthy nasal carriers, but did not find any agr III isolate (26). Most exofoliatin producing strains responsible for Staphylococcal Scalded Skin Syndrome (SSSS) belongs to group IV (11). The agr group IV was absent in many previously reported articles (23, 26, 15, 22), nevertheless, we detected agr group IV (9.5%) in our experiments that was more likely due to ecological and geographical differences. Goerke et al. reported that the majority of S. aureus strains, taken from patients undergoing intubations, belonged to group III (5). Manago et al. found that most of agr I strains show poor biofilm formation, compared with other agr groups. They also found a lower prevalence of group I strains and a higher prevalence of group II strains in the nosocomial infections (15). Most of the agr group I clones which had been previously reported by the Brazilian, Portuguese, Hungarian and Berlin Research Groups. Group II strains were mainly isolated in Japan and North America. On the other hand, strains of group III were mainly isolated in Europe (8). Recent data demonstrate that the vast majority of MRSA in France and around the world belongs to agr group III (20, 3). Our experience revealed that group I is the most prevalent group in Iran, followed by groups III, II and IV. Iran is one of the several countries with high antibiotic resistance rate, including methicillin resistance. Therefore, it is important to emphasize on the verification of characteristics of MRSA in this country. This report has evaluated the correlation between agr groups and antibiotic resistance in Iran population. This result will be helpful to encourage verification of the characteristics of MRSA in other Asian countries. In addition, this study may also aid in evaluating the global spread of MRSA strains based on agr locus polymorphisms.There seems to be a geographic distribution difference between agr groups.
We thank Professor Richard P. Novick (Skirball Institute, New York) for generously providing standard strains and Dr. Patrice Francois for standard DNA controls. Moreover, we thank Dr. Yousof Gheisari and Ehsan Arefian for their assistance in statistical analyses.
1. Arbuthnott, J.P.; Coleman, D.C.; de Avazedo, J.S. (1990). Staphylococcal toxins in human disease. Soc Appl Bacteriol Symp Ser.19:s101-7. [ Links ]
2. Balaban, N.; Novick, R.P. (1995). Autocrine regulation of toxin synthesis by Staphylococcus aureus. Proc. Natl. Acad Sci USA. 92: 1619-1623. [ Links ]
3. Dufour, P.; Gillet, Y.; Bes, M.; Lina, G.; Vandenesch, F.; Floret, D. et al. (2002). Community-acquired Methicillin-Resistant Staphylococcus aureus infections in France: emergence of a single clone that produces panton-valentin leukocidin. Clin Infect Dis. 35:819-824. [ Links ]
4. Fischetti, V.A.; Novick, R.P.; Ferretti, J.J.; Portnoy, D.A.; Rood, J.I.; editors (2000). Pathogenicity factors and their regulation. Gram-positive pathogens. Washington DC: ASM Press.392-407. [ Links ]
5. Georke, C.; Kymmel, M.; Dietz, K.; Wolz, C.; (2003). Evaluation of interspecies interference due to agr polymorphism in Staphylococcus aureus during infection and colonization. J Infect Dis. 188:250-256. [ Links ]
6. Gi, J.; Beavis, R.; Novick, R.P. (1997). Bacterial interference caused by autoinducing peptide variants. Science. 276: 2027-2030. [ Links ]
7. Gold, H.S.; Moellering, R.C. (1996).Antimicrobial-drug resistance. Engl. J. Med. 335:1445-1453. [ Links ]
8. Gomes, A.R.; Vinga, S.; Zavolan, M.; de Lencastre, H. (2005). Analysis of the genetic variability of virulence-related loci in epidemic clones of Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 49:366-379. [ Links ]
9. Grisold, A.J.; Leitner, E.; Muhlbauer, G.; Marth, E.; Kessler, H.H. (2002). Detection of Methicillin Resistant Staphylococcus Aureus and simultaneous confirmation by automated nucleic acid extraction and Real-Time PCR. J. Clin. Microbiol. 40: 2392-2397. [ Links ]
10. Hiramatsu, K.; Chui, L.; Kuroda, M.; Ito, T. (2000). The emergence and evolution of methicillin resistant Staphylococcus aureus. Trends. Microbiol. 9:486-493. [ Links ]
11. Jarraud, S.; Lyon, G.J.; Figueiredo, J.M.; Jerard, L.; Vandenesch, F.; Etienne, J. et al. (2000). Exofoliatin-producing strains define a forth agr specificity group in Staphylococcus aureus. J Bacteriol. 182:6517-6522. [ Links ]
12. Jarraud, S.; Mougel, C.; Thioulous, J.; Lina, G.; Meugnier, H.; Forey, F.; Nesme, X.; Etienne, J.; Vandenesch, F. (2002). Relation between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles) and human diseases. Infect. Immun. 70:631-641. [ Links ]
13. Kohel, J.L.; Muthaiyan, A.; Jayaswal, R.K.; Ehlert, K.; Labinschinski, H.; Wilkinson, B.J. (2004). Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 48:3749-3757. [ Links ]
14. Lina, G.; Gillet, Y.; Vandenesch, F.; Jones, M.E.; Floret, D.; Etienne, J. (1997). Toxin involvement in staphylococcal scalded skin syndrome. Clin Infect Dis. 25:1369-73. [ Links ]
15. Manago, K.; Nishi, J.; Wakimoto, N.; Miyanohara, H.; Sarantuya, J.; Tokuda, K.; Iwashita, M.; Yamamato, K.; Yoshinaga, M.; Maroyama, I.; Kwano, Y. (2006). Biofilm formation by and accessory gene regulator typing of Methicillin-Resistant Staphylococcus aureus strains recovered from patients with nosocomial infections. Infect Control Hosp Epidemiol. 27:188-190. [ Links ]
16. Moise-broder, P.A.; Sakulas, J.; Eliopoulos, G.M.; Schentag, J.J.; Forrest, A.; Moellering, R.C. (2004). Accessory gene regulator group II polymorphism in Methicillin-Resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis. 38:1700-1705. [ Links ]
17. Naimi, T.S.; LeDell, K.H.; Como-Sabetti, K.; Borchardt, S.M.; Boxrud, D.J.; Etienne, J.; Johnson, S.K.; Vandenesch, F.; Fridkin, S.; O'Boyle, C.; Danila, R.N.; Lynnfield, R. (2003). Comparison of community and health care associated Methicillin Resistant Staphylococcus aureus infection. JAMA. 290:2976-2984. [ Links ]
18. Novick, R.P. (2003). Autoinduction and signal transduction in the regulation of Staphylococcal virulence. Mol Microbiol. 48:1429-1449. [ Links ]
19. Panlilio, N.L.; Culver, D.H.; Gaynes, R.P.; Banerjee, S.; Henderson, T.S.; Tolson, J.S.; Martone, W.J. (1992). Methicillin Resistant Staphylococcus aureus in U.S hospitals ,1975-1991. Infect. Hosp Control. Epidemiol. 13:582-586. [ Links ]
20. Pearman, J.W. (2002). Community-acquired MRSA: the Australian experience [abstract 359]. In: program and abstracts of the 10th international symposium on Staphylococci and Staphylococcal diseases (Tsukuba, Japan). Japan: Japan Symposium on Staphylococci and Staphylococcal. Disease. p 18. [ Links ]
21. Sakoulas, G.; Eliopoulos, G.M.; Mollering, R.C.; Wennersten, C.; Venkataraman, L.; Novick, R.P.; Gold, H.R. (2002). Accessory gene regulator (agr) locus in geographically divers Staphylococcus aureus isolates with reduces susceptibility to vancomycin. Antimicrob Agents Chemother. 46:1492-1502. [ Links ]
22. Sakulas, G.; Eliopoulos, G.M.; Moellering, R.C.; Novick, R.P.; Venkataraman, L.; Wennersten, C.; DeGirolami, P.C.; Schwaber, M.J.; Gold, H.S. (2003). Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J. Infect. Dis. 187:929-938. [ Links ]
23. Shopsin, B.; Mathema, B.; Alcabes, P.; Said-Salim, B.; Lina, G.; Matuska, A.; Matinez, J.; Kreiswirth, B. (2000). Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardian's Clin Microbil. 1:456-459. [ Links ]
24. Stefani, S.; Varaldo, P.E. (2003). Epidemiology of methicillin resistance staphylococci in Europe. Clin. Microbiol. Infect. 9: 1179-1186. [ Links ]
25. Takeushi, S.; Maeda, T.; Hashimoto, N.; Imaziumi, K.; Kaidoshi, T.; Hayakawa, Y. (2001). Variation of the agr locus in Staphylococcus aureus isolates from cows with mastitis. Vet Microbiol. 79:267-274. [ Links ]
26. Van Leeuwen, W.; Van Nieuwenhuizen, W.; Gijzan, C.; Vebrugh, H.; Van Belkum, A. (2000). Population studies of Methicillin Resistant and Sensitive Staphylococcus aureus strains reveal a lack of variability in the agrD gene, encoding a Staphylococcal autoinducer peptide. J Bacteriol. 182: 5721-5729. [ Links ]
27. Voss, A.; Milatovic, D.; Wallarauch-Schwarz, C.; Rosdahl, V.T.; Braveny, I (1994). Methicillin Resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 13:50-55. [ Links ]
28. Wayane, P.A. (2000). National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 7th ed. Approved standard M2-A7. [ Links ]
29. Wright, J.S.; Traber, K.E.; Corrigan, R.; Benson, S.A.; Musser, J.M.;Novick, R.P. (2005). The agr radiation: an early event in the evolution of staphylococci. J Bacteriol, 16: 5585-5594. [ Links ]
30. Yarwood, J.M.; Schielvert, P.M. (2003). Quorum sensing in Staphylococcus infections. J Clin Invest., 11: 1620-1625 [ Links ]
Submitted: March 31, 2011
Returned to authors for corrections: November 09, 2011
Approved: January 16, 2012